Black Diamond Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | +83.3% | +6.8% | +10.6% | +294.2% | +147.8% | -14.0% | -21.5% | -5.2% | |
| – | +1,180.0% | +5,592.2% | +113.1% | +80.8% | -13.1% | -21.3% | +10.7% | -37.6% | |
| – | -83.6% | +12,651.9% | -0.6% | +82.0% | -33.0% | – | – | – | |
| – | -79.7% | +30.8% | +989.0% | +39.2% | -241.0% | – | -173.0% | – | |
| – | -1.3% | -72.4% | +576.2% | +1,808.5% | -92.9% | -82.8% | -100.0% | – | |
| – | -1.3% | -72.4% | +1,341,285.7% | – | -59.1% | -69.4% | +3.8% | -364.6% | |
| – | +421.9% | +147.6% | +66.0% | -99.7% | -75.7% | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | +424.5% | +144.2% | +68.2% | -99.7% | -75.7% | +40,539.5% | -64.5% | -100.6% | |
| – | +480.2% | +135.4% | -215.4% | – | -201.1% | – | -191.8% | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.